CA
NZ
UK
AU
IND
US
Abeona Therapeutics Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 6, 2026, the company entered into an Asset Purchase Agreement with Ellodi Pharmaceuticals, L.P. to acquire substantially all assets related to the clinical-stage EoE candidate APT-1011, and separately closed …
Sable Offshore Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a nine-month net loss of $530,564 thousand and first-time oil and gas revenues following the restart of …
National Healthcare Properties, Inc. filed a Form 8-K on November 9, 2026, disclosing that its Board of Directors elected Jeffrey S. Olson and Craig S. Smith as new independent directors, effective November 9, 2026, following a board expansion from six to eight members.
John Howard Goss Jr., SVP and President of Sally Beauty at Sally Beauty Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of five tranches of restricted stock units on November 4, 2026.
Director Lawrence Yau Lung Ho filed a Form 4 with the SEC on November 9, 2026, disclosing purchases of Class A ordinary shares of Studio City International Holdings Ltd on November 5 and November 6, 2026, through a corporate affiliate.
Haleon plc filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing the aggregated details of ordinary share purchases made between November 2 and November 6, 2026, under its share buyback programme announced on October 29, 2026.
ImmunityBio, Inc. filed a Form 8-K on November 9, 2026, disclosing that ANKTIVA plus Bacillus Calmette-Guérin met the primary endpoint in Cohort A of its BCG-naive non-muscle invasive bladder cancer randomized QUILT-2.005 trial.
CKX Lands, Inc. filed a Form 8-K on November 9, 2026, disclosing the execution of a definitive investment agreement with Jacobs Private Equity II, LLC and other investors for an aggregate equity investment of $1,000,000,000 in cash.
LAU Michael Kwok Yan, together with Moon Shadow Global Limited and Moonglade Investment Limited, filed a Schedule 13D with the SEC on November 9, 2026, disclosing beneficial ownership of Class B Ordinary Shares of Energys Group Ltd following a reclassification of the issuer's ordinary …
CKX Lands, Inc. filed a current report on November 9, 2026, disclosing the execution of a definitive investment agreement with Jacobs Private Equity II, LLC and other investors for an aggregate equity investment of $1,000,000,000 in cash.
Please wait processing your request...